GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Resources
      • GM Myth Makers
      • Gene Editing
      • Non-GM successes
      • GM Quotes
      • GM Myths
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
      • GM Booklet
      • GM Book
    • Contact
    • About
    • Search
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
  • Resources
    • Non-GM Successes
    • GM Myth Makers
    • Gene Editing
    • GM Quotes
    • GM Myths
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
    • GM Booklet
    • GM Book
  • Donations
  • Contact
  • About
  • Search

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

GENE EDITING MYTHS, RISKS, & RESOURCES

Gene Editing Myths and Reality

Bayer has not proposed paying $8 billion to settle US Roundup claims: mediator

  • Print
  • Email
Details
Published: 09 August 2019
Twitter

Update

Here's an update on the Bloomberg story we put out earlier.
---

Bayer has not proposed paying $8 billion to settle U.S. Roundup claims: mediator

Reuters, 9 Aug 2019
https://www.reuters.com/article/us-bayer-glyphosate-feinberg/bayer-has-not-proposed-paying-8-billion-to-settle-u-s-roundup-claims-mediator-idUSKCN1UZ1FA

Bayer AG has not proposed paying $8 billion to settle all U.S. claims related to the Roundup herbicide, mediator Ken Feinberg said in an email on Friday.

“Such a statement is pure fiction,” Feinberg said. “Compensation has not even been discussed in the global mediation discussions.”

Bayer acquired Roundup and other glyphosate-based weedkillers through its $63 billion takeover of Monsanto last year. It has faced a wide array of litigation over Roundup’s alleged cancer risks.

Reporting by Jonathan Stempel in New York; Editing by Steve Orlofsky

Menu

Home

Subscriptions

News Archive

News Reviews

GM Book

Resources

Non-GM Successes

GM Myth Makers

GM Myths

GM Quotes

GM Booklet

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2025 GMWatch.
Web Development By SCS Web Design